Research supports better integration of patient voice in health technology assessments
The research will help ensure new treatments reflect the needs and preferences of patients and family members living with myeloma and other conditions.
Read More
Tag: Myeloma UK
Myeloma UK trial to test novel myeloma treatment approach
Myeloma UK has launched a nationwide trial aiming to assess the effectiveness of a novel treatment combination that includes Darzalex for patients with genetically-defined high-risk myeloma.
Read More
Myeloma UK gets £1m donation
The DFN Charitable Foundation is donating £1 million to charity Myeloma UK to help support the development of advanced genomic and genetic research tools to better characterise, monitor and treat the disease.
Read More
Myeloma UK launches ‘world first’ immunotherapy trial
Myeloma UK has launched a ground-breaking immunotherapy trial which aims to modulate the immune system to target myeloma.
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
